Per previous
terms of clearance--and given that the burden estimates continue to
swing dramatically from submission to submission--approval is
granted for 2 years so that the estimates are more frequently
updated. Where burden estimates swing dramatically, FDA should
attempt to reassess estimates more frequently to ensure that the
estimates on record are accurate. To the extent that the swings are
actually due to poor estimation, FDA should attempt to improve the
way estimates are produced.
Inventory as of this Action
Requested
Previously Approved
10/31/2011
36 Months From Approved
10/31/2009
64,805,294
0
2,702,413
2,629,106
0
2,702,413
0
0
0
The regulations that are the subject
of this information collection implement PDMA. PDMA was enacted by
Congress because there were insufficient safeguards in the drug
distribution system to prevent the introduction and retail sale of
substandard, ineffective, or counterfeit drugs, and that a
wholesale drug diversion submarket had developed that prevented
effective control over the true sources of drugs. Congress found,
amont other things, that large amounts of drugs had been reimported
into the U.S. as U.S. goods returned causing a health....
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.